SFB 1309 - Chemical Biology of Epigenetic Modifications







Saint Nicolas Symposium       

December 6, 2019

Römerforum (K00.015), BioSysM Building   



09:00    Prof. Dr. Thomas Carell



09:10    Prof. Dr. Anjana Rao

             La Jolla Institute for Immunology, USA

             “Paradoxical association of TET loss of function with genome-

               wide hypomethylation”


10:10    Prof. Dr. Michaela Frye

             Deutsches Krebsforschungszentrum Heidelberg, DE

             “Cytosine-5 RNA methylation in stem cells and cancer“


11:15    Coffee break


11:45    Prof. Dr. Petra Hajkova

             Imperial College London, UK

             “Molecular principles of developmental reprogramming”


12:45    Lunch break and Poster session


14:30    Prof. Dr. Juri Rappsilber

             TU Berlin, DE

             “Cellular cartography at molecular detail: in situ crosslinking

              mass spectrometry”


15:30    Prof. Dr. Dirk Schwarzer

            Universität Tübingen, DE

            “Development and utilization of chemical probes for investigating

             histone modification“


16:30    Coffee break


17:00    Prof. Dr. Cynthia Burrows

             University of Utah, USA

            “Interplay of guanine oxidation and G-quadruplex folding

              in gene promoters”



Ludwig-Maximilians-Universität München

BioSysM building, room K00.015

Butenandtstr. 1

81377 München




February 3, 2020     

Vorlesung : " Wie entstehen Arzneimittel-Innovationen?" von Prof. Wolfgang Plischke

Nach Teilnahme an der Vorlesung findet am 12. Mai 2020 eine kostenlose Exkursion zu den Forschungseinrichtungen der Bayer AG statt. Teilnahmeliste wird zur Vorlesung ausliegen. Nähere Infos erteilt Frau Martina.Schuster@cup.uni-muenchen.de














Headquarters of the SFB1309 will be the Institute for Chemical Epigenetics Munich ICEM
which is currently under construction.



The Collaborative Research Centre (SFB 1309) "Chemical Biology of Epigenetic Modifications" deals with the small chemical modifications of biomolecules. These epigenetic changes represent a second information level in the genetic makeup and play a crucial role in the regulation of various vital processes. The new CRC aims at explaining the chemical language of the modifications and at better understanding its origin and function. To do so, the scientists want to examine epigenetic mechanisms with the help of analytic and synthetic methods and identify the proteins involved. This way, the way for new options for the therapy of diseases such as cancer and certain mental disorders is to be opened up and paved.

TU München